Daclatasvir and Sofosbuvir Therapy Enhance Monocyte Phenotypic Changes in Naive Chronic Hepatitis C Patients: A Prospective Cohort Study

Daclatasvir and Sofosbuvir Therapy Enhance Monocyte Phenotypic Changes in Naive Chronic Hepatitis C Patients: A Prospective Cohort Study

Background. Liver inflammation influences monocyte function, recruitment, and consequently inflammatory and fibrogenic responses. We aimed to investigate changes in the circulating monocyte phenotypes in response to Daclatasvir-Sofosbuvir (SOF/DCV) therapy in chronic hepatitis C (CHC) and relate fin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hanan M. Fayed, Ali A. Ghweil, Mona M. AbdelMeguid
Format:	Article
Language:	English
Published:	Wiley 2019-01-01
Series:	Interdisciplinary Perspectives on Infectious Diseases
Online Access:	http://dx.doi.org/10.1155/2019/9469567
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Resistance-Associated Substitutions (RAS) and Clinical Factors as Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients
by: Juferdy Kurniawan, et al.
Published: (2024-10-01)

Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C
by: L. Tang, et al.
Published: (2018-01-01)

Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma: Clinical Application to Therapeutic Drug Monitoring
by: Naser F. Al-Tannak, et al.
Published: (2018-01-01)

The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Efficacy of daclatasvir and asunaprevir for viral hepatitis С in two donor lung recipients
by: D. T. Abdurakhmanov, et al.
Published: (2018-08-01)

NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy
by: M. V. Mayevskaya, et al.
Published: (2015-12-01)

Sofosbuvir Based Regimens in the Treatment of Chronic Hepatitis C with Compensated Liver Cirrhosis in Community Care Setting
by: Vijay Gayam, et al.
Published: (2018-01-01)

Real-world effectiveness of sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir against genotype 3 hepatitis C virus infection: a systematic review and meta-analysis
by: Liwei Zhuang, et al.
Published: (2025-02-01)

Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China
by: Chengguang Hu, et al.
Published: (2018-01-01)

Successful Treatment of Hepatitis C with Simeprevir, Sofosbuvir, and Ribavirin in an HIV Coinfected Liver Transplant Patient with Advanced Chronic Kidney Disease
by: Anna Maruyama, et al.
Published: (2016-01-01)

Real-life study on the effectiveness and safety of sofosbuvir/velpatasvir-based antiviral agents for hepatitis C eradication in Chinese patients
by: Jiayi Wang, et al.
Published: (2024-12-01)

Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir
by: Ali Nada, et al.
Published: (2020-01-01)

Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection
by: Yong-yu Mei, et al.
Published: (2020-01-01)

Autoimmunity and Extrahepatic Manifestations in Treatment-Naïve Children with Chronic Hepatitis C Virus Infection
by: Giuseppe Indolfi, et al.
Published: (2012-01-01)

Comparative monocyte and T cell responses in DENV-exposed subjects from South-East Asia and DENV-naïve residents in Taiwan
by: Sheng-Hsuan Wang, et al.
Published: (2025-02-01)

In vivo regulation of the monocyte phenotype by Mycobacterium marinum and the ESX-1 type VII secretion system
by: Kristina Munke, et al.
Published: (2025-02-01)

Interferon-γ Stimulates Monocyte Chemotactic Protein-1 Expression by Monocytes
by: J. M. Liebler, et al.
Published: (1994-01-01)

Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to Ribavirin
by: Hirokazu Suii, et al.
Published: (2017-01-01)

Apelin Serum Level in Egyptian Patients with Chronic Hepatitis C
by: Hala O. El-Mesallamy, et al.
Published: (2011-01-01)

Acute stimulation of PBMCs drives switch from dopamine-induced anti- to proinflammatory phenotype of monocytes only in women
by: Leonie Fleige, et al.
Published: (2025-02-01)

Monocyte Heterogeneity: Consequences for Monocyte-Derived Immune Cells
by: Sara Sprangers, et al.
Published: (2016-01-01)

Long-Term Real-World Outcomes of Tenofovir Alafenamide in Chronic Hepatitis B: Detailed Analysis of Treatment-Naive and Experienced Patients
by: Yu-Xuan Song, et al.
Published: (2025-01-01)

An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function
by: Shyam Patel, et al.
Published: (2016-01-01)

Screening of Primary School Children for Amblyopia and Amblyogenic Factors in Central Cairo, Egypt
by: Mohammad A. Rashad, et al.
Published: (2018-01-01)

A naiv Wittgenstein
by: Ádám Szabó
Published: (2010-04-01)

Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α
by: Kaimin Song, et al.
Published: (2025-02-01)

Expression of LAIR-1 (CD305) on Human Blood Monocytes as a Marker of Hepatic Cirrhosis Progression
by: María Martínez-Esparza, et al.
Published: (2019-01-01)

Tofacitinib downregulates JAK1 and JAK3 on human intestinal monocytes and macrophages without affecting dendritic cells phenotype or function
by: Elisa Arribas-Rodríguez, et al.
Published: (2025-06-01)

Dynamic monocyte changes as prognostic indicators in operable gastric cancer: a retrospective cohort analysis
by: Yiwei Jiang, et al.
Published: (2025-02-01)

Monocyte to High‐Density Lipoprotein Ratio Is Associated With Carotid Plaque: A Retrospective Cohort Study
by: Shuang Liu, et al.
Published: (2025-02-01)

Sex differences in the peripheral levels of cytokines during 12-month antipsychotic treatment in a drug-naïve schizophrenia spectrum cohort
by: I. Ratke, et al.
Published: (2025-03-01)

Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER study)
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)

Classification Of Prospective Scholarship Recipients Kartu Indonesia Pintar (KIP) With Decision Tree Algorithm And Naïve Bayes
by: Asnimar, et al.
Published: (2022-12-01)

Visual-Evoked-Response-Supported Outcome of Intravitreal Erythropoietin in Management of Indirect Traumatic Optic Neuropathy
by: Mohammad Ahmad Rashad, et al.
Published: (2018-01-01)

Advanced Glycation End Products Enhance Murine Monocyte Proliferation in Bone Marrow and Prime Them into an Inflammatory Phenotype through MAPK Signaling
by: Xian Jin, et al.
Published: (2018-01-01)

Phenotypic Description of the Spanish Multicentre Genetic Glaucoma Group Cohort
by: Elena Milla, et al.
Published: (2017-01-01)

The Role of Monocyte/Macrophage and CXCR3 in Differentiation between Recurrent Hepatitis C and Acute Cellular Rejection Postliver Transplantation
by: Asmaa Ibrahim Gomaa, et al.
Published: (2018-01-01)

Simeprevir and Sofosbuvir Combination Treatment in a Patient with HCV Cirrhosis and HbS Beta 0-Thalassemia: Efficacy and Safety despite Baseline Hyperbilirubinemia
by: Nikolaos Papadopoulos, et al.
Published: (2016-01-01)

Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study
by: Guilherme Thomé de Carvalho, et al.
Published: (2025-02-01)

Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study
by: Guanghui Ren, et al.
Published: (2025-02-01)